Maximum Dose of Crestor (Rosuvastatin)
The maximum recommended dose of rosuvastatin is 40 mg once daily for most patients, but this must be reduced to lower maximums (5-20 mg daily) depending on specific drug interactions and patient characteristics. 1
Standard Maximum Dosing
- The FDA-approved maximum dose is 40 mg orally once daily for the general adult population without contraindications or significant drug interactions 1
- The therapeutic dosage range spans 5 mg to 40 mg once daily, with high-intensity statin therapy defined as rosuvastatin 20-40 mg daily (achieving 50-63% LDL-C reduction) 2
- Rosuvastatin can be administered at any time of day, with or without food, as a single daily dose 1
Critical Dose Restrictions Based on Drug Interactions
Several commonly used medications require strict maximum dose limitations well below 40 mg:
Severe Restrictions (5 mg maximum daily):
- Cyclosporine, tacrolimus, everolimus, or sirolimus: Do not exceed 5 mg daily due to 7-fold increase in rosuvastatin exposure and severe rhabdomyolysis risk 2, 3, 1
- Darolutamide: Maximum 5 mg daily 1
Moderate Restrictions (10 mg maximum daily):
- Teriflunomide, enasidenib, capmatinib, regorafenib: Do not exceed 10 mg daily 1
- Gemfibrozil: Avoid concomitant use if possible; if used together, maximum 10 mg daily 1
- Antiviral medications (atazanavir/ritonavir, lopinavir/ritonavir, simeprevir, dasabuvir/ombitasvir/paritaprevir/ritonavir, elbasvir/grazoprevir, sofosbuvir/velpatasvir, glecaprevir/pibrentasvir): Maximum 10 mg daily 1
- Severe renal impairment (CrCl <30 mL/min/1.73 m² not on hemodialysis): Maximum 10 mg daily 1
Intermediate Restrictions (20 mg maximum daily):
- Fostamatinib, febuxostat: Do not exceed 20 mg daily 1
- Tafamidis: Avoid concomitant use if possible; if used together, maximum 20 mg daily 1
- Resmetirom (for MASH/NASH): Limit rosuvastatin to 20 mg daily 2
Contraindicated Combinations:
- Sofosbuvir/velpatasvir/voxilaprevir and ledipasvir/sofosbuvir: Concomitant use not recommended 1
Special Population Considerations
Asian Patients:
- Initiate at 5 mg once daily due to increased rosuvastatin plasma concentrations in this population 1
- Consider risks and benefits carefully when treating Asian patients requiring doses above 20 mg daily 1
Pediatric Patients:
- Ages 8 to <10 years with HeFH: Maximum 10 mg daily 1
- Ages ≥10 years with HeFH: Maximum 20 mg daily 1
- Ages ≥7 years with HoFH: Recommended dose 20 mg daily 1
Elderly Patients (>75 years):
- While no specific dose restriction exists, moderate-intensity therapy (5-10 mg) may be more appropriate than high-intensity therapy, as there was no clear evidence of additional cardiovascular benefit from high-intensity therapy in this age group 2
Common Pitfalls to Avoid
- Never exceed 5 mg daily with immunosuppressants (cyclosporine, tacrolimus, everolimus, sirolimus) as this creates a severe drug-drug interaction through OATP1B1 and P-glycoprotein inhibition 2, 3
- Always check for drug interactions before prescribing or increasing doses, as multiple commonly used medications require dose restrictions 1
- Do not administer rosuvastatin simultaneously with aluminum and magnesium hydroxide antacids—separate by at least 2 hours 1
- Screen for renal impairment before prescribing higher doses, as severe renal impairment mandates a 10 mg maximum 1